INFLUENCE OF PROBIOTIC SUPPLEMENTATION ON CLIMACTERIC SYMPTOMS IN MENOPAUSAL WOMEN-A MINI REVIEW
Menopause (MP) is a natural physiological event of womanâ€™s life and is defined as the absence of menstrual periods for at least twelve months and loss of function of ovarian. The common symptoms of MP are irregular vaginal bleeding, hot flushes especially in head and chest, night sweats, insomnia, vaginal and urinary symptoms, cognitive dysfunction, increased cancer risk, osteopenia, high blood pressure, diabetes, and cardiovascular diseases. Microbiome has been associated with several health benefits. Probiotic supplementation helps to enhance the quality of microbiome thereby confers the health benefits to the host system. The microbiome, hormone (estrogen) changes, and probiotic intervention are related to the health status of the female reproductive system. The vaginal microbiome (VM) play a critical role in female reproductive health and MP, which can be greatly influenced by probiotics, and other medicine especially antibiotics and hormone therapy. The role of VM in supporting vaginal health is not clear and debatable. Understanding the role of vaginal Lactobacillus could expose the pathogenesis of vaginal dysbiosis, which helps to improve diagnostic and therapeutic strategies for several dysbiosis associated health issues and menopause-related symptoms. Recent studies suggested that the intervention of probiotic preparation with or without nutraceutical formulation (mostly with isoflavones) improve the health status of menopausal women. The mechanism of probiotics mediated health improvement in menopausal women is not yet described clearly. Several controversies are there on the link between probiotic, gut microbiota, vaginal microbiota, and estrogen deficit. The present review summarizes the influence of probiotic supplementation on climacteric symptoms in menopausal women. The literature search was made in Scopus, Google Scholar, PubMed using the keywords â€œprobioticsâ€ and â€œmenopauseâ€. The documents were carefully checked for the relevance to the current manuscript, and the selection was made without any restriction in the year of publication.
2. Monteiro NES, Queiros LD, Lopes DB, Pedro AO, Macedo GA. Impact of microbiota on the use and effects of isoflavones in the relief of climacteric symptoms in the menopausal women-a review. J Funct Foods 2018;41:100-11.
3. Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 2011;38:425-40.
4. Davis S. Menopause. Nat Rev Dis Primers 2015;1:15004.
5. Mohammed K, Moain A, Dabrh A, Benkhadra K, Nofal AA, Leon BGC, et al. Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. J Clin Endocrinol Metab 2015;100:4012-20.
6. Roussouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. JAMA 2002;288:321-33.
7. Beral V. Breast cancer and hormone-replacement therapy in a million women study. Lancet 2003;362:419-27.
8. Rozenberg S, Vandromme J, Antoine C. Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol 2013; 9:216-27.
9. Ensrud KE, Joffe H, Guthrie KA, Larson JC, Reed SD, Newton KM, et al. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause 2012;19:848-55.
10. Moreira AC, Silva AM, Santos MS, Sardao VA. Phytoestrogens as alternative hormone replacement therapy in menopause: what is real, what is unknown. J Steroid Biochem Mol Biol 2014; 143:61-71.
11. Sivamaruthi BS, Kesika P, Chaiyasut C. Probiotic based therapy for atopic dermatitis: outcomes of clinical studies. Asian Pac J Trop Biomed 2018;8:328-32.
12. Doron SI, Hibberd PL, Gorbach SL. Probiotics for the prevention of antibiotic-associated diarrhea. J Clin Gastroenterol 2008;42:S58-63.
13. Isolauri E, Rautava S, Salminen S. Probiotics in the development and treatment of allergic disease. Gastroenterol Clin North Am 2012;41:747-62.
14. Tomaro Duchesneau C, Saha S, Malhotra M, Jones ML, Labbe A, Rodes L, et al. Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Appl Microbiol Biotechnol 2014;98:115-26.
15. Dylag K, Hubalewska Mazgaj M, Surmiak M, Szmyd J, Brzozowski T. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr Pharm Des 2014;20:1149-55.
16. Di Gioia D, Aloisio I, Mazzola G, Biavati B. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Appl Microbiol Biotechnol 2014;98:563-77.
17. Dib W, Chekroun A, El-Ghaish S, Choiset Y, Chobert J, Haertle T, et al. Effects of orally administered enterococcus faecium on the immune systemic response and intestinal epithelial structure in Balb/c mice immunized by bovine Î²-lactoglobulin. Int J Pharm Pharm Sci 2014;6:587-90.
18. Bharti V, Mehta A, Singh S, Jain N, Ahirwal L, Mehta S. Bacteriocin: a novel approach for preservation of food. Int J Pharm Pharm Sci 2015;7:20-9.
19. Demers M, Dagnault A, Desjardins JA. Randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr 2014;33:761-7.
20. Sirilun S, Sivamaruthi BS, Kumar N, Kesika P, Peerajan S, Chaiyasut C. Lactobacillus-fermented plant juice as a potential ingredient in cosmetics: formulation and assessment of natural mouthwash. Asian J Pharm Clin Res 2016;9(Suppl 3):52-6.
21. Sivamaruthi BS. A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases. Asian Pac J Trop Biomed 2018;8:179-86.
22. Sivamaruthi BS, Chaiyasut C, Kesika P. Cosmeceutical importance of fermented plant extracts: a short review. Int J Appl Pharm 2018;10:31-4.
23. Sivamaruthi BS, Kesika P, Chaiyasut C. A review on anti-aging properties of probiotics. Int J Appl Pharm 2018;10:9-12.
24. Vieira AT, Castelo PM, Ribeiro DA, Ferreira CM. Influence of oral and gut microbiota in the health of menopausal women. Front Microbiol 2017;8:1884.
25. Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas 2010;66:333-43.
26. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011;108(Suppl 1):4680-7.
27. van de Wijgert JH, Borgdorff H, Verhelst R, Crucitti T, Francis S, Verstraelen, et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One 2014;9:e105998.
28. Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol 2015;6:81.
29. Younes JA, Lievens E, Hummelen R, van der Westen R, Reid G, Petrova MI. Women and their microbes: the unexpected friendship. Trends Microbiol 2018;26:16-32.
30. Hillier SL, Lau RJ. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis 1997;25(Suppl 2):S123-6.
31. Cauci S, Driussi S, De Santo D, Penacchioni P, Iannicelli T, Lanzafame P, et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri-and postmenopausal women. J Clin Microbiol 2002;40:2147-52.
32. Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K. Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis 2003;188:1054-8.
33. Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis, PLoS One 2010;5:e10197.
34. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012;4:132-52.
35. Martin DH. The microbiota of the vagina and its influence on womenâ€™s health and disease. Am J Med Sci 2012;343:2-9.
36. Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas 2016;91:42-50.
37. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 2000;30:901-7.
38. Mirmonsef P, Hotton AL, Gilbert D, Burgad D, Landay A, Weber KM, et al. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One 2014;9:e102467.
39. Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2008;141:54-7.
40. Palacios S, Rojo Ial, Cancelo MJ, Neyro JL, Castelo-Branco C. Womenâ€™s perception of the efficacy of a soy extract with probiotic: the M3 study. Gynecol Endocrinol 2008;24:178-83.
41. Jaisamrarn U, Triratanachat S, Chaikittisilpa S, Grob P, Prasauskas V, Taechakraichana N. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric 2013;16:347-55.
42. Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 2014;229:1822-30.
43. Trimarco V, Rozza F, Izzo R, De Leo V, Cappelli V, Riccardi C, et al. Effects of a new combination of nutraceuticals on postmenopausal symptoms and metabolic profile: a crossover, randomized, double-blind trial. Int J Womens Health 2016;8:581-7.
44. Lambert MNT, Thorup AC, Hansen ESS, Jeppesen PB. Combined red clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms. PLoS One 2017;12:e0176590.
45. Marschalek J, Farr A, Marschalek ML, Domig KJ, Kneifel W, Singer CF, et al. Influence of orally administered probiotic Lactobacillus strains on vaginal microbiota in women with breast cancer during chemotherapy: a randomized placebo-controlled double-blinded pilot study. Breast Care (Basel) 2017;12:335-9.
46. Liong MT. Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Nutr Rev 2017;65:316-28.
47. Otieno DO, Ashton JF, Shah NP. Stability of Î²-glucosidase activity produced by Bifidobacterium and Lactobacillus spp. in fermented soy milk during processing and storage. J Food Sci 2005;70:M236-41.
48. Cheung AL, Wilcox G, Walker KZ, Shah NP, Strauss B, Ashton JF, et al. Fermentation of calcium-fortified soya milk does not appear to enhance acute calcium absorption in osteopenic post-menopausal women. Br J Nutr 2011;105:282-6.
49. Guadamuro L, Delgado S, Redruello B, Florez AB, Suarez A, Martinez-Camblor P, et al. Equol status and changes in fecal microbiota in menopausal women receiving long-term treatment for menopause symptoms with a soy-isoflavone concentrate. Front Microbiol 2015;6:777.